Prevention of Infectious Mastitis by Oral Administration ofLactobacillus salivariusPS2 During Late Pregnancy
Author(s) -
Leónides Fernández,
Nívia Cárdenas,
Rebeca Arroyo,
Susana Manzano,
Esther Jiménez,
Virginia Martín,
Juan M. Rodrı́guez
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ974
Subject(s) - lactobacillus salivarius , medicine , mastitis , pregnancy , oral administration , lactobacillus , immunology , food science , biology , pathology , genetics , fermentation
Previous studies have shown that oral administration of lactobacilli can be an efficient approach to treat lactational infectious mastitis. In this trial, we have evaluated the potential of Lactobacillus salivarius PS2 to prevent this condition when orally administered during late pregnancy to women who had experienced infectious mastitis after previous pregnancies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom